Cyclin D1 antibody (C-Term)
Quick Overview for Cyclin D1 antibody (C-Term) (ABIN927860)
Target
See all Cyclin D1 (CCND1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - C-Term
 - 
                                            
Cross-Reactivity
 - Mouse (Murine)
 - 
                                            
Purification
 - Purified
 - 
                                            
Immunogen
 - Ccnd1 antibody was raised in rabbit using the C terminal of Ccnd1 as the immunogen
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - 
                        WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Concentration
 - Lot specific
 - 
                                            
Buffer
 - Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
 - 
                                            
Handling Advice
 - Avoid repeated freeze/thaw cycles.
 - 
                                            
Storage
 - 4 °C/-20 °C
 - 
                                            
Storage Comment
 - Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
 
 - 
                                            
 - 
    
- Cyclin D1 (CCND1)
 - 
                                            
Alternative Name
 - Ccnd1
 - 
                                            
Background
 - Ccnd1 is essential for the control of the cell cycle at the G1/S (start) transition. Synonyms: Polyclonal Ccnd1 antibody, Anti-Ccnd1 antibody, cyclin D1 antibody, AI327039 antibody, Cyl-1 antibody, PRAD1 antibody, bcl-1 antibody, cD1 antibody.
 - 
                                            
Pathways
 - PI3K-Akt Signaling, Cell Division Cycle, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
 
Target
 -